A study to evaluate the safety and efficacy profile of Formoterol/fluticasone-propionate in patients with asthma in real world setting
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms AffIRM
- 18 Sep 2017 New trial record
- 12 Sep 2017 According to a Mundipharma media release, data from the study has been presented at the European Respiratory Society International Congress (ERS) 2017.
- 12 Sep 2017 Results published in a Mundipharma media release.